Movano Health Implements 1-for-10 Reverse Stock Split to Regain Compliance

Movano Health's Strategic Move: The 1-for-10 Reverse Stock Split

On October 8, 2025, Movano Health (Nasdaq: MOVE) took a significant step toward stabilizing its stock by announcing a 1-for-10 reverse stock split set to become effective on October 10, 2025, at 12:01 a.m. Eastern Time. This strategic decision aims to increase the bid price of the company's common stock to ensure compliance with Nasdaq's minimum bid price requirement, which is crucial for maintaining its listing.

The Nature of the Reverse Stock Split

In this reverse split, every ten shares of Movano's pre-split common stock will convert into one share of the newly reclassified common stock. This action will reduce the company's outstanding shares from approximately 8.3 million down to roughly 0.8 million. The total number of authorized shares will remain unchanged, meaning that the overall market capitalization of Movano Health will not be affected by this technical adjustment.

Implications for Stockholders

For stockholders, this means that any fractional shares that arise from the reverse stock split will not be issued; instead, shareholders will receive cash for those fractional interests. Furthermore, adjustments will be made concerning the exercise prices and the number of shares pertaining to Movano’s equity plans to ensure proportional equity for existing shareholders.

Rationale Behind the Split

Movano Health's Board of Directors resorted to this route following stockholder authorization received at the annual meeting on September 26, 2025. The reverse stock split is often employed as a strategic measure to enhance a company's stock price, making it more appealing to institutional investors and ensuring compliance with stock exchange standards. As stock prices drop, companies often face challenges in trading viability and market perception; thus, such adjustments can enhance liquidity and mitigate risk.

Next Steps and Trading Resumption

Trading of the adjusted common stock under the symbol 'MOVE' is anticipated to resume on a split-adjusted basis on October 10, 2025, in The Nasdaq Capital Market. However, stockholders holding shares in book-entry format will receive a transaction notification from the company's transfer agent, Pacific Stock Transfer Company, indicating their new share count.

About Movano Health

Founded in 2018, Movano Inc. operates under the name Movano Health and is recognized for developing innovative healthcare solutions, primarily focusing on wearables. The flagship product, the Evie Ring, illustrates their commitment to delivering medical-grade data that prioritizes health management. Movano Health aims to transform health monitoring through devices that blend technology with personal health insights, ensuring users receive actionable and intelligent feedback about their well-being.

In conclusion, while reverse stock splits can often trigger skepticism regarding a company’s financial health, Movano Health's intentions seem to align with a constructive plan to navigate the challenges of being a publicly traded entity. The focus remains on innovation and improvement, making their future within the healthcare industry promising yet reliant upon prudent stock management and corporate governance.